乳酸・グリコール酸共重合体のマイクロスフェアの製剤設計.ゲンタマイシンのin Vitroの放出性の解析
スポンサーリンク
概要
- 論文の詳細を見る
The sustained release mechanism of gentamicin (GM) from lactic acid/glycolic acid copolymer (PLGA) microspheres was investigated. The terminal free carboxyl group of polymer was proved to be necessary for GM to be highly incorporated into microspheres by comparing interactions with GM and two types of polymers ; free (ionized and non ionized) and the terminal esterified carboxyl group of polymer. The weight-average molecular weights (MWS) of component PLGAs of microspheres with an ionizable carboxyl group used here were approximately 4900 and 10000. The release pattern of GM was tested in phosphate buffered saline. The release rate of GM was dependent on the initial MW and surface form. The GM release continued for 20 and 30 d from PLGA 4900- and PLGA10000-microspheres, respectively. The changes of total weight of microspheres tended to decrease with time, and the molecular weight distribution of PLGA gradually shifted to lower distribution, indicating a decrease in MW. The changes and the shifts were dependent on the initial MWS of PLGAs but independent of their surface form. The half-times of wight loss of PLGA 4900- and PLGA10000-microspheres were about 10 and 20 d, respectively. From these results, the release profile of GM from PLGA microspheres was explained by the following three steps, i.e., 1) the release from the surface, 2) the relatively slow release caused by the obstruction of channels followed by the degradation of PLGA, 3) the release accompanied by the erosion of microspheres.
- 公益社団法人日本薬学会の論文
- 1994-12-25
著者
-
平野 耕一郎
塩野義製薬 中研
-
平野 耕一郎
塩野義製薬株式会社研究所
-
高岸 靖
塩野義製薬製造部
-
高岸 靖
塩野義製薬株式会社研究所
-
高岸 靖
塩野義製薬(株)研究所製剤研究部
-
竹島 和男
塩野義製薬株式会社研究所
-
長田 俊治
塩野義製薬株式会社研究所
-
竹島 和男
塩野義製薬株式会社 中央研究所
関連論文
- スルファメトキサゾールの製剤加工度のBioavailabilityに及ぼす影響
- Sulfamethoxazole/Trimethoprim複合体の溶解挙動とバイオアベイラビリティー
- 高速液体クロマトグラフ法による血中のAcetohexamideおよびその代謝物Hydroxyhexamideの定量
- Studies on Drug Nonequivalence. VII. Bioavailability of Acetohexamide Polymorphs
- Studies on Drug Nonequivalence. VI. Physico-chemical Studies on Polymorphism of Acetohexamide
- 製剤技術の展望 : 21世紀へ向けて
- 噴霧乾燥式流動層造粒法による医薬品粉末注射剤の製造
- B-16 硬カプセル剤の識別性と嗜好性に関する検討
- 薬物水溶液の凍結相中での結晶化
- 乳酸・グリコール酸共重合体のマイクロスフェアの製剤設計.ゲンタマイシンのin Vitroの放出性の解析
- New Application of Human Tumor Clonogenic Assay to in Vitro Evaluation of Tumor-Targeting Efficiency of Immunoconjugates
- 生分解性高分子マイクロスフェアからの薬物の放出性に及ぼす形態的特性の影響
- Encapsulation of Drugs by Lyophilized Empty Dipalmitoylphosphatidylcholine Liposomes : Effect of Calcium Ion
- Encapsulation of Drugs by Lyophilized, Empty Dipalmitoylphosphatidylcholine Liposomes
- Studies on the Absorption of practically Water-insoluble Drugs following Injection. IV. An Approach for Predicting Relative Intramuscular Absorption Rates of a Drug in Oily Solution, Aqueous Suspension and Aqueous Surfactant Solution in Rats
- Studies on the Absorption of practically Water-insoluble Drugs following Injection. III. Intramuscular Absorption from Aqueous Nonionic Surfactant Solutions in Rats
- Studies on the Absorption of practically Water-insoluble Drugs following Injection. II. Intramuscular Absorption from Aqueous Suspensions in Rats
- Studies on the Absorption of practically Water-insoluble Drugs following Injection. I. Intramuscular Absorption from Water-immiscible Oil Solutions in Rats
- リポソームと混合したインターロイキン-2(Lipo-IL2)の体内動態とマウスM5076細網肉腫の肝転移に及ぼす治療効果
- ビーグル犬の胃内液酸度
- 血中および尿中のピンドロールの高速液体クロマトグラフィーによる定量
- DDS的アイデアによる創薬支援研究 (興奮性アミノ酸受容体アンタゴニストの腎蓄積軽減)
- 生体試料中のセファレキシンの高速液体クロマトグラフィーによる定量法
- タイトル無し